Material Balance of [14C]Zorifertinib in Healthy Adult Male Participants in China

Clinical trial NCT07620951 · RECRUITING

Trial details

NCT number: NCT07620951
Sponsor: Alpha Biopharma (Jiangsu) Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

EGFR Mutant Advanced Non-small Cell Lung Cancer Central Nervous System (CNS) Metastases

Start date: 2026-07-06
Primary completion: 2026-08-01
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.